cancer from semaglutide Do or Tirzepatide cause thyroid cancer? Weight-loss drugs may lower cancer

Disclosure: I hold a bullish position in Altimmune (ALT) through call options expiring January 2027 a leveraged, directional position that profits if the stock rises

Can I take Ozempic with Levothyroxine for PCOS

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the

Higher doses typically produce greater weight loss, but individual response varies based on genetics and metabolism

mL = milliliter

3 High Growth GLP-1 Biotech Winners to Buy in July